Imricor Medical Systems Past Earnings Performance
Past criteria checks 0/6
Imricor Medical Systems's earnings have been declining at an average annual rate of -12.9%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 2.1% per year.
Key information
-12.9%
Earnings growth rate
9.6%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 2.1% |
| Return on equity | n/a |
| Net Margin | -2,458.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Imricor Medical Systems makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -20 | 7 | 8 |
| 31 Mar 24 | 1 | -21 | 7 | 8 |
| 31 Dec 23 | 1 | -23 | 8 | 8 |
| 30 Sep 23 | 1 | -20 | 8 | 8 |
| 30 Jun 23 | 0 | -17 | 8 | 7 |
| 31 Mar 23 | 1 | -17 | 8 | 8 |
| 31 Dec 22 | 1 | -17 | 8 | 8 |
| 30 Sep 22 | 1 | -18 | 8 | 9 |
| 30 Jun 22 | 1 | -20 | 9 | 9 |
| 31 Mar 22 | 1 | -20 | 9 | 10 |
| 31 Dec 21 | 1 | -20 | 9 | 10 |
| 30 Sep 21 | 1 | -18 | 8 | 9 |
| 30 Jun 21 | 1 | -17 | 7 | 8 |
| 31 Mar 21 | 1 | -15 | 7 | 7 |
| 31 Dec 20 | 1 | -12 | 6 | 6 |
| 30 Sep 20 | 1 | -13 | 5 | 5 |
| 30 Jun 20 | 1 | -14 | 5 | 4 |
| 31 Mar 20 | 1 | -14 | 4 | 4 |
| 31 Dec 19 | 1 | -13 | 3 | 4 |
| 30 Sep 19 | 1 | -11 | 3 | 4 |
| 30 Jun 19 | 0 | -8 | 2 | 4 |
| 31 Mar 19 | 1 | -7 | 2 | 4 |
| 31 Dec 18 | 1 | -5 | 2 | 4 |
| 31 Dec 17 | 0 | -5 | 2 | 4 |
| 31 Dec 16 | 1 | -4 | 2 | 3 |
Quality Earnings: IMR is currently unprofitable.
Growing Profit Margin: IMR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IMR is unprofitable, and losses have increased over the past 5 years at a rate of 12.9% per year.
Accelerating Growth: Unable to compare IMR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IMR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Return on Equity
High ROE: IMR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.